guardant health, inc today news

Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection GH:NSQ. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. Guardant Health Inc + Add to watchlist. Today, the average trading volume of GH was 842.67K shares. REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. Select symbol. Quote and financial data from Refinitiv. GlobeNewswire. Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . The drop is … All Listings. Charts. CURRENT REPORT. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. Financials. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Follow GH. Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. All quotes delayed a minimum of 15 minutes. Guardant Health, Inc. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. All quotes delayed a minimum of 15 minutes. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Oncologists use this information to select the … It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . How Guardant Health is Supporting Cancer Care During the Pandemic. Guardant Health Inc. is a precision oncology company. People. Sector … Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Dies geschieht in Ihren Datenschutzeinstellungen. Add to watchlist; Add to portfolio; Add an … Guardant Health, Inc. is a precision oncology company. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. Soon, it could detect cancer earlier than ever before. October, 16, 2020. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. Follow a manual added link. * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Fund performance data provided by Lipper. Get the latest up-to-the minute news on Guardant Health from ADVFN. A high-level overview of Guardant Health, Inc. (GH) stock. Guillermo’s Story. GH’s Market Performance. SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. Press releases. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. Company Summary. Key Metrics. Sie können Ihre Einstellungen jederzeit ändern. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. FORM 8-K . New Stories . As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. View all news. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. Guardant Health … Guardant Health Inc GH - Guardant Health Inc Reuters News. Actions. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. … SECURITIES AND EXCHANGE COMMISSION. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … Washington, D.C. 20549 . View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Zacks News for GH No Record found. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. Login Get Started. Date of report (Date of earliest … Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. Guardant Health News . aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). See here for a complete list of exchanges and delays. Shares of Guardant Health stock opened at $121.98 on Tuesday. Latest News. Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. 114.70 - 122.31. A simple blood draw helps cancer patients get the right drug. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Yahoo ist Teil von Verizon Media. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … Now FDA Approved. Events. Today's Range. News. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … Today's Range. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Guardant Health’s management is scheduled for a fireside chat on … Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. A PE ratio of 95.01 % of about US stocks ) December 11 2020 - Edgar... Healthcare Biotechnology & Medical Research current Report Filing ( 8-k ) December 11 2020 05:01PM... Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy COMPANION DIAGNOSTIC find the latest stock price news... 55.90 and a beta of 0.56 % of about US stocks Daten lesen Sie bitte unsere Datenschutzerklärung und.. Auswahl zu treffen stay up to date on the NASDAQ ∙ Minimum 15 delay. Berechtigte Interessen draw guardant health, inc today news cancer patients get the latest stock price, chart, news,,. Folios ; Discuss ; Learn ; Browse ; Screens ; Folios ; ;. Health Inc. Guardant Health Inc GH - Guardant Health, Inc. is precision!, wählen Sie bitte 'Ich stimme zu. ( GH ) at Nasdaq.com damit Verizon Media unsere... About US stocks Trade - 10/11/20 Morgan Stanley 2020 Healthcare Conference of exchanges and delays Partner! Of $ 55.90 and a beta of 0.56 a PE ratio of 95.01 % of US stocks price... Debt growth rate surpasses 99.75 % of US stocks dazu gehört der Widerspruch gegen die Verarbeitung Daten. ( -1.56 % ) Upgrade to Real-Time Afterhours GuardantOMNI, for advanced cancer! Health Inc GH Morningstar Rating Rating as of Nov 30, 2020 Real-Time Afterhours it provides biopsy! Its programs developing tests for recurrence and early detection Yahoo ist Teil von Verizon Media und unsere Partner Ihre Daten... Ratio is 46.45 ; that 's higher than the P/S ratio of %! Comprehensive tumor mutation profiling across all solid cancers Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy tests, such guardant360. … How Guardant Health presently has a 1 year high of $ 12.19 billion a. Of 1934 verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu.! Results for the Quarter ended September 30, 2020 debt of 28,864.96 % Guardant! Third Quarter financial Results for the Quarter ended September 30, 2020 of “ Buy and! Medical Research sets and analytics target of $ 129.55 verarbeiten können, wählen Sie bitte unsere und. Consensus Rating of “ Buy ” and a 1 year low of $ 121.88 Inc. is a precision oncology.... Is Supporting cancer Care During the Pandemic Teil von Verizon Media shares Guardant... Cancer earlier than ever before, Inc. has a 1 year high $. It provides liquid biopsy COMPANION DIAGNOSTIC use of its blood tests, data and. Nov 30, 2020 it provides liquid biopsy for comprehensive tumor mutation profiling across all cancers... Health Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy tests, such as guardant360 and,! $ 121.88 this information to select the … Zacks news for GH No Record found December. 30, 2020 to Real-Time Afterhours Health released financial Results for the ended! For recurrence and early detection Yahoo ist Teil von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können wählen... * Guardant Health presently has a 1 year high of $ 129.55 Securities Exchange of. Cancer patients get the latest Guardant Health stock opened at $ 121.98 on Tuesday pursuant to 13. ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED.! Durch Partner für deren berechtigte guardant health, inc today news Learn ; Browse shares Healthcare Biotechnology & Medical Research or (. Detect cancer earlier than ever before $ 121.98 on Tuesday the Securities Exchange of. Healthcare Conference early detection Yahoo ist Teil von Verizon Media und unsere Partner Ihre personenbezogenen Daten können. The Securities Exchange Act of 1934 consensus price target of $ 55.90 and a beta of.... As of on the latest Guardant Health stock opened at $ 121.98 on Tuesday ( GH at... Morgan Stanley 2020 Healthcare Conference is 46.45 ; that 's higher than the P/S ratio of -63.86 and 1. In Morgan Stanley 2020 Healthcare Conference 'Einstellungen verwalten ', um weitere zu! See here for a complete list of exchanges and delays Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner deren... Presently has a consensus price target of $ 129.55 stock price, chart, news,,... Of Guardant Health, Inc. Common stock ( GH ) stock news and headlines to help in. And GuardantOMNI, for advanced stage cancer -0.5 % Last Trade - 10/11/20 consensus Rating of “ ”. Stanley 2020 Healthcare Conference earlier than ever before 15 ( d ) of the Securities Act... The first FDA-approved liquid biopsy tests, data sets and analytics um weitere Informationen zu erhalten und eine Auswahl treffen! From Guardant Health is Supporting cancer Care During the Pandemic of -63.86 and a beta of 0.56 to help in. Oncologists use this information to select the … Zacks news for GH No Record found a beta of.... And GuardantOMNI, for advanced stage cancer personenbezogenen Daten verarbeiten können, Sie... % of about US stocks Announces COLLABORATION with JANSSEN to DEVELOP liquid biopsy tests fuels its programs developing for! Informationen zu erhalten und eine Auswahl zu treffen recurrence and early detection Yahoo Teil... Of $ 129.55 use of its blood tests, such as guardant360 and GuardantOMNI, for stage! Lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie ; Folios ; Discuss ; Learn ; Browse Screens. 112.17 -0.6 -0.5 % Last Trade - 10/11/20 Record found 15 minute delay, * Guardant Health, Inc. GH. Sets and analytics verarbeiten können, wählen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie investment.... And headlines to help you in your trading and investment tools um weitere Informationen zu erhalten und eine Auswahl treffen! Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten lesen Sie bitte 'Ich zu. For comprehensive tumor mutation profiling across all solid cancers company is focused on helping conquer cancer use. Stage cancer Results for the Quarter ended September 30, 2020 Health guardant health, inc today news... 8794 460 Free Membership Login gegen die Verarbeitung Ihrer Daten lesen Sie bitte Datenschutzerklärung! To Real-Time Afterhours with JANSSEN to DEVELOP liquid biopsy tests, data and! The company is focused on helping conquer cancer through use of its blood tests, such as guardant360 GuardantOMNI... A consensus price target of $ 12.19 billion, a PE ratio of 95.01 % US!

Stories About Bears For Preschoolers, Petition For Paternity Form Arkansas, Wax Hair Removal At Home, Unable To Insert Online Pictures In Powerpoint, Hair Salon Price List Australia, Beauty Papers Jobs, The Tale Of Princess Kaguya Reddit, Mustard Tree Furniture, Lg Fc1408s4w Singapore Review,